Synulox boluses have a notably broad spectrum of bactericidal activity against bacteria commonly found in calves.
In vitro Synulox is active against a wide range of clinically important bacteria including Gram-positive and Gram-negative bacteria.
The clinical indications for Synulox boluses are in the treatment of enteritis and navel ill in calves.
Administration
By the oral route.
Dosage rate
6.25–12.5 mg/kg bodyweight twice daily, e.g. a 40 kg calf will require ½ bolus twice daily, but this may be doubled in cases of severe infection.
Treatment should be continued for up to 12 hours after the clinical signs have subsided to a maximum of 3 days of treatment.
Contra-indications, warnings, etc
Animals must not be slaughtered for human consumption for 9 days following the last treatment.
Do not use in animals with known sensitivity to the active ingredients.
In common with other penicillins, the product should not be administered orally to rabbits, guinea pigs, hamsters or gerbils.
The combination is of a low order of toxicity and is well tolerated by the oral route. Limited overdose normally produces no adverse effects.
Operator warning
Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross reaction to cephalosporins and vice-versa. Allergic reaction to these substances may occasionally be serious.
Pharmaceutical precautions
Do not store above 25°C. Store in a dry place.
Dispose of any unused product and empty containers in accordance with guidance from your local waste regulation authority.
Keep out of the sight and reach of children.
For animal treatment only.
